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Abstract
Background: Cancer is the second leading cause of death in developing countries. In Iran, cancer
is the third cause of death. The present study aimed at providing the incidence rates (crude and age-
standardized) of different types of cancers in Sistan and Baluchestan province (Southeastern of Iran).
Methods: Data were collected retrospectively reviewing all new cancer patients registered in Can-
cer Registry Center of Health Heputy for Sistan and Baluchestan province. Common cancers were
defined based on the number of cases and standardized incidence rates. To compute the annual per-
centage change (APC), joinpoint 4.1.1.1 software was applied.
Results: A total of 3535 cases of cancers registered during 2004-2009 were identified. Of these,
46.82% occurred in females and 53.18% in males. The most frequent cancer in women was breast
cancer followed by esophagus, skin, colorectal and leukemia. The 5 most frequent cancers in men
were stomach, skin, leukemia, esophagus and bladder. Joinpoint analyze showed a significant in-
creasing trend for adjusted standard incidence rate (ASIR) for both sexes (p<0.05).
Conclusion: According to The results of the present study and comparison to previous studies for
other provinces in Iran, cancer incidence in Sistan and Baluchistan is less common but trends of can-
cers are increasing in Sistan and Baluchestan Province. It is necessary to have a comprehensive
health policy for prevention and control of this problem.
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Introduction
Cancer is the unhindered growth and
spread of abnormal cells (1). There may be
important difference between developed
and developing countries regarding epide-
miology of cancers. Changing the environ-
ment and people’s lifestyle caused by the
present rapid advancement of industrializa-
tion in developing countries, may change
the epidemiologic patterns of various can-
cers in these regions (2, 3). In the past, we
considered the cancers as the diseases be-
longed to western countries since they were
uncommon in other regions, but now are
frequently diagnosed in less developed or
economically transitioning countries and
their rates are increasing (4). In the devel-
oping world, in addition to the increasing
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trends, the future burden of cancers is likely
to be exasperated by the expected increases
in life expectancy and aging and growth of
the population (5). Also this is predicted
that The percentage of cases diagnosed in
less developed countries will increase from
about 56% in 2008 to more than 60% in
2030 (6). It is also estimated that cancer
will go beyond ischemic heart disease as
the main cause of death worldwide (7). To-
day, in countries with Western lifestyle,
nearly half of the deaths are because of car-
diovascular diseases, and one-fourth of
deaths are due to cancers. Public health is
influenced by cancer as a serious problem
in today’s world (8). Cancer and related
lifestyle diseases are increasing across Asia
and already responsible for half of the dis-
ease-associated mortality in the vast ma-
jority of the countries (9). About 7.6 mil-
lion cancer deaths occured throughout the
world in 2008, and about 60% of cancer
deaths occur in low-income and middle-
income countries and this number is prone
to increase in the future. It is estimated that
more than a quarter of a million people will
die yearly in the Eastern Mediterranean
Region (EMRO) alone. Iran is member of
the EMRO. The most common cancers in
the EMRO are breast cancer in females,
and lung and bladder cancers in males(10).
Age specific incidence rate for all cancer in
world is 205.4 (per 100000 population) and
mortality rate is 126.3 per 100000 popula-
tion in 2012; this rate is respectively 174.1
and 126.3 in the Asia and also is 134.7 and
90.4 in Iran(11).
In Iran located in epidemiologic transi-
tion, cancer is the third cause of death after
coronary heart disease, accidents and other
factors (12-14). Incidence of cancer is in-
creasing in developing countries because of
aging and cancer associated lifestyle such
as smoking, physical inactivity, obesity,
and stress. The estimates predict that the
number of new cases of cancer from 10
million per year in 2000 will rise to 15 mil-
lion in 2020, and approximately 60% oc-
curs in developing countries (15). Iran has
experienced an increase in population in the
last decades as well as changes in lifestyle
and socioeconomic status. Incidence rate of
cancer is 98-100 per 100,000 populations in
Iran (12). The geographic differences in the
incidence of specific cancers have been
previously reported; hence it is of great im-
portance to illuminate the epidemiology of
neoplastic disease in different regions (12,
16).
The present study aimed at providing the
incidence rates (crude and age-
standardized) of different types of cancers
in Sistan and Baluchestan province, located
in south-east Iran, and to compare these
rates with that of other regions throughout
the country and the world. To the best of
our knowledge, this is the first population-
based research assessing the incidence of
different cancers in Sistan and Baluchestan
province, Sistan and Baluchestan province
is one of the 31 provinces of Iran, located
in the south-east of the country (Fig. 1) as
one of the largest provinces of Iran with an
area of 181,785 km² and 70,188 sq mi(17).
According to the 2011 census, the total
population of Sistan and Baluchestan prov-
ince was about 2,534,327 people, and the
male/female ratio was 1,268,748:
1,265,579. Given that, the main goal of this
study was to describe the distribution of
cancer incidence rate and 6 year trends
(2004-2009) in order to provide evidence
for plan primary preventive and control
plans.
Fig. 1. Geographic situation of Sistan and Baluchestan,
Iran
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Methods
Data collection and analysis
This analytic study was done based on
longitudinal national registry of cancer
(NCR) program in Iran. Data used in this
study was obtained from NCR, and Disease
Control and Prevention (CDC) report of
Iran Ministry of Health and Medical Educa-
tion from 2004 to 2009 for Sistan and Ba-
luchestan (18). Cancer registry system has
been designed and implemented in Iran
since 1986 and the first report was pub-
lished in 1986. Data were collected retro-
spectively reviewing all new cancer pa-
tients registered in Cancer Registry Center
of Health Deputy for Sistan and Ba-
luchestan during a 6-year period (2004 -
2009). Data were included demographic
characteristics like age, sex residency, date
of diagnosis which were coded based on
International Classification of Diseases for
Oncology (ICD-O)(19). After referring data
to NCR, the data were modified based on
the recorded patients’ addresses; so that
Sistan and Baluchestan patients’ data rec-
orded in other provinces of Iran were ag-
gregated into this province data; duplicated
cases and non-resident patients were also
removed.
Statistical analysis
We calculated Age-Standardized Inci-
dence Rate (ASIR) (per 100,000 persons)
using direct standardized method and world
standard population (20). To describe inci-
dence time trends, we used Joinpoint Re-
gression Program, Version 4.1.1.1. The
analysis included logarithmic transfor-
mation of the rates, maximum number of
one joinpoints, and minimum of 6 years
between zero joinpoints. All other program
parameters were set to default values. The
test of significance was based on the Monte
Carlo Permutation method (i.e., it finds
“the best fit” line). Joinpoint regression
analysis involves fitting a series of joined
straight lines on a log scale to the trends. In
this test 0 joinpiont is null hypothesis and 1
joinpoint the alternate hypothesis. The aim
of this approach is to identify possible join-
points where a significant change in the
trend occurs. The final model selected was
the most parsimonious of these, with the
estimated annual percent change (APC)
based on the trend within each segment and
estimated annual average percent change
(AAPC) for full model trend. In describing
trends, the terms “significant increase” or
“significant decrease” signify that the slope
of the trend was statistically significant (p<
0.05). All statistical tests were two sided.
Results
During 6 years (2004 -2009) in Sistan and
Baluchestan province, a total of 3535 cases
of cancers have been registered. Of these,
46.82% (1655 cases) occurred in females
and 53.18% (1880 cases) in males. Cancer
incidence sex ratio (male to female) for this
study is 1.13. Most frequent Cancer cases
within this period time were reported in
2009, including 379 females and 430 males
(Table 1).
ASIR shows an increasing trend for the
both sexes during 2004 - 2009; ASIR has
increased from 22.20 to 35.29 in females
and from18.95 to 35.99 in males (Fig. 2).
In this study, for adjusted ASIR trend, 0
joinpoint (Full model) and 1 joinpoint were
selected model for male and female, re-
spectively.
Joinpoint analyze showed a significant
Table1. Frequency and ASIR of cancers by sex in Sistan and Baluchestan during 2004 to 2009
Male Female Total M:F
Year Count ASIR Count ASIR Count ASIR
2004 172 18.95 163 22.20 335 20.57 1.05
2005 267 29.80 210 25.08 477 27.44 1.27
2006 324 32.83 276 30.55 600 31.69 1.17
2007 345 34.81 316 34.31 661 34.56 1.09
2008 342 34.74 311 33.65 653 34.20 1.10
2009 430 35.99 379 35.29 809 35.64 1.13
ASIR: Age-standardized incidence rate (per 100,000 persons)
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increasing trend for adjusted ASIR for both
sexes (p<0.05). Average annual percent
change (AAPC) for men was 11.2 and for
women 9.5 (Table 2).
The most common cancers in both sexes
were as follows: skin (10.35%), esophagus
(8.43%), breast (8.06%), stomach (7.98%)
and leukemia (6.93%), respectively. The
average ASIR and frequency of cases with-
in the years 2003 to 2009 revealed the five
most common cancers in females and
males; so these five cancers consisted of
47.43% and 43.99% of all female and male
cancers, respectively (Table 3).
The ASIR showed an increasing trend for
cancers in Sistan and Baluchestan; so that
the breast cancer rate in females was 1.96
in 2004 and increased to 5.37 in 2009. Al-
so, ASIR of esophageal cancer and colorec-
tal cancer in females were 2.08 and 1.77 in
2004, which increased to 4.01 and 3.04 in
2009, respectively. The rate of most com-
mon cancers in males increased from 0.37
in 2004 to 1.33 in 2009.  The incidence
rates (per 100 000 person-year) of cancers
were 2.75, 2.22, 1.35, 1.21 and 1.24 in
2004 for stomach, skin, leukemia, esopha-
gus and bladder cancer, respectively. How-
ever, these rates have increased to 4.48,
3.05, 2.31, 2.82 and 2.27 respectively in
2009. In 2004 compared to 2009, among
the five most common cancers, breast can-
cer had most  increasing  rate with incre-
mental coefficient of 1.74 for ASIR in fe-
Fig. 2. ASIR trend of cancers in Sistan and Baluchestan by sex between 2004 and 2009
Table 2. Joinpoint analyses of cancers incidence in Sistan and Baluchestan during 2004 to 2009
Full Range (2004-2009) Trend 1 (2004-2006) Trend 2 (2006-2009)
AAPC* 95% CI APC** 95% CI APC** 95% CI
Male 11.2^ 0.4 to 23.3
Female 9.5^ 5.4 to 14.8 15.8 -12.2 to 52.6 0.7 -42 to 75.1
*.APC (Annual Percent Change) and **.AAPC (Average Annual Percent Change)
^.APC or AAPC is significantly different from zero at alpha = 0.05
Table 3. Five common cancers by sex, Sistan and Baluchestan, 2004-2009
Rank 1 2 3 4 5
Women Cancer Breast Esophagus Skin Colorectal Leukemia
Total Number 274 163 153 102 93
Mean ASR 4.77 3.14 2.95 1.91 1.53
Men Cancer Stomach Skin Leukemia Esophagus Bladder
Total Number 208 213 152 135 119
Mean ASR 3.72 3.46 2.24 2.20 2.15
Both Sex Cancer Skin Esophagus Breast Stomach Leukemia
Total Number 366 298 285 282 245
ASIR: Age-standardized incidence rate (per 100,000 persons)
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males and lung cancer with incremental
coefficient of 1.33 for ASIR in males .
Discussion
In this study, the sex ratio (male to fe-
male) for incidence of cancer was 1.13. The
high rate of cancer incidence among Iranian
males has also been reported for other
provinces of Iran. In a study carried out in
Qom, of all cancer cases, 58% were male
and 42% female (21). In a study  by kousha
et al on epidemiology of cancers in the East
Azerbaijan province, this ratio (male to fe-
male) was 1.38 (22). In a study by Norouzi
Nejad et al carried out in Mazandaran prov-
ince on epidemiology of cancers, this ratio
was 1.2. To this regard, it should be noted
that in the all mentioned studies, population
sex ratio was not equal (23). The resent
study showed a significant increasing trend
for the cancer rates in sistan and balouch-
estan province that is consistent with other
studies in the region and the country.
This study showed a significant increas-
ing trend with the average annual percent-
age change (AAPC) 11.2 in men and 9.5 in
women, respectively, this increase is simi-
lar to other studies conducted in other Ira-
nian provinces. A study in Kerman prov-
ince six-year trend of cancer incidence by
Joinpoint was studied and a significant in-
creasing trend in annual percentage chang-
es (APC) was revealed (12.1 in women and
7.11 in men) (14).
In a study conducted in Yazd, Vakili et al
reported that increasing trends of cancers
for males and females were significant
from 2005 to 2009. In the Vakili's study the
age-standardized incidence rate in females
increased from 84.6 to 94.8 and this rate
increased from 85.9 to 113.8 for males
(13). Mokarian's study carried out to inves-
tigate the epidemiology and cancer trends
in Isfahan province during 2005 to 2010
showed an increasing incidence rate so that
ASIR in 2005 was 107 and changed to
124.9 in 2010 (24). The standardized inci-
dence rates in Sistan and Baluchestan prov-
ince during 2004 to 2009, increased from
18.95 to 35.99 for males and 22.20 to 35.29
for females.  A part of this increase was as
a result of improvement in cancer registra-
tion in Iran. Cancer Registry System in Iran
was pathology based and 80% of cancers
were recorded in the best of circumstances.
Cancer registry system in Iran changed to
population based since 2009, so this meth-
od caused an increase of cancer registration
(25).
In a study that investigated world pattern
and mortality rate of cancer, Jemal et al
showed an increasing rates of cancers for
Asian countries (7). Other studies for the
trend of gastric cancer in Iran showed a
significant increasing trend in APC; 11.7
for women and 9.18 for men (3).
In Talaiezadeh's study that investigated
cancer incidence rate in Khuzestan prov-
ince between 2002 and 2009, top 5 highest
ASIRs in males were skin (16), bladder
(10.7), prostate (7.64), stomach (7.17) and
colorectal (6.32); in females, these were
breast (26.4), skin (13.6), colorectal (7.52),
stomach (4.31) and bladder(4.07), respec-
tively (26). In a study by Vakili et al in
Yazd (2005 - 2009), it was indicated  that
the most prevalent cancers were skin, blad-
der, colorectal, stomach and prostate in
males and breast, skin, colorectal, gastric
and leukemia in females (13). The present
study was based on the average ASIR dur-
ing 2004 and 2009, and showed the most
frequent cancers were gastric (3.72), skin
(3.46), leukemia (2.24), esophagus (2.20)
and bladder cancer (2.15) and the most
common cancers in females were breast
cancer (4.77), esophagus (3.14), skin
(2.95), colorectal (1.91) and leukemia
(1.53) .
A study of cancer facts and Figures in
2014 estimated that the most frequent can-
cers in were prostate, lung, colorectal,
bladder, and skin and in males,  and breast,
lung, colorectal, uterine corpus and thyroid
in females, respectively (1). According to
studies, the ASIR in 2008 for the South-
Central Asia region, was 104.6 and by sex
was 110.8 for males and 99.7 for females
(15). According to the results of current
study, ASIR for Sistan and Baluhestan
D
ow
nl
oa
de
d 
fro
m
 m
jiri
.iu
ms
.ac
.ir 
at 
13
:58
 IR
ST
 on
 Tu
es
da
y J
an
ua
ry 
28
th 
20
20
Cancer Epidemiology and Trends in Sistan and Baluchestan province…
6 Med J Islam Repub Iran 2015 (29 August). Vol. 29:254.http://mjiri.iums.ac.ir
province in 2008 is 34.20 for both males
and females (34.74 in males and 35.65 in
females).
According to the results of the present
study and comparison to previous studies in
other provinces, cancer incidence in Sistan
and Baluchistan is less common. The ASIR
in Sistan and Baluchistan in 2004 was
20.57 and increased to 35.64 in 2009. In the
study of Yazd province, ASIR was 85.20 in
2005 and 104.7 in 2009. This rate in the
East Azerbaijan province in 2006 was
133.20 for both  males and females and
148.96 in males and 108.10 in females (22).
Differences in the types and incidence
rate of cancers in different geographic areas
is the result of multiple factors. Several
studies have identified at least 500 different
types of cancer-causing agents, of which
5% to 10% are genetic factors and 90% to
95% environmental factors and lifestyle of
people (27). Therefore in this study, lower
incidence rates in various types of cancers
in Sistan and Baluchestan can be attributed
to the mentioned reasons.
One of the main limitation of this study is
the data collected from the Cancer Registry
of Ministry of Health which are limited to
the type of cancer, incidence, sex and age.
Another limitation was lack of information
related to subjects’ lifestyle and their edu-
cation, occupation and socio-economic sta-
tus.
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